ERBB2 and breast carcinoma: Carbonic anhydrases strongly predict survival of patients with HER2-enriched breast cancer displaying low (Fig. 11H) but not high (Fig. 11I) levels of pro-inflammatory cytokines and transcription factors in the tumor tissue.